Enhanced Cell Osteogenic Differentiation in Alendronate Acid and Flufenamic Acid Drug-Impregnated Nanoparticles of Mesoporous Bioactive Glass Composite Calcium Phosphate Bone Cement In Vitro
This study aims to compare the anti-osteoporotic drugs alendronic acid (ALN) and flufenamic acid (FA) alone impregnate into nanoparticles of mesoporous bioactive glass (nMBG), which further composites calcium phosphate cement (CPC) and investigates their in vitro performance. The drug release, physi...
Main Authors: | Shih-Ming Liu, Jian-Chih Chen, Ssu-Meng Huang, Shang-Hong Lin, Wen-Cheng Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/5/680 |
Similar Items
-
Injectability, Processability, Drug Loading, and Antibacterial Activity of Gentamicin-Impregnated Mesoporous Bioactive Glass Composite Calcium Phosphate Bone Cement In Vitro
by: Ming-Hsien Hu, et al.
Published: (2022-08-01) -
The effect of mesoporous silica doped with silver nanoparticles on glass ionomer cements; physiochemical, mechanical and ion release analysis
by: Syed Saad Bin Qasim, et al.
Published: (2024-10-01) -
In Vitro Evaluation of Calcium Phosphate Bone Cement Composite Hydrogel Beads of Cross-Linked Gelatin-Alginate with Gentamicin-Impregnated Porous Scaffold
by: Shih-Ming Liu, et al.
Published: (2021-09-01) -
Treatment of critical bone defects using calcium phosphate cement and mesoporous bioactive glass providing spatiotemporal drug delivery
by: Richard Frank Richter, et al.
Published: (2023-10-01) -
Optimizing α-tricalcium phosphate bone cement composite formulations: The critical role of bioactive glass particle size
by: Öznur Demir, et al.
Published: (2024-12-01)